Pharmacogenomics in the era of next generation sequencing – from byte to bedside
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics in the era of next generation sequencing – from byte to bedside
Authors
Keywords
-
Journal
DRUG METABOLISM REVIEWS
Volume -, Issue -, Pages 1-26
Publisher
Informa UK Limited
Online
2021-04-06
DOI
10.1080/03602532.2021.1909613
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mouse NTCP–Mediated Rosuvastatin Uptake In Vitro and in Slc10a1-Deficient Mice
- (2021) Laura E. Russell et al. AAPS Journal
- CYP2C9 and CYP2C19 : Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants
- (2020) Lingxin Zhang et al. CTS-Clinical and Translational Science
- Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7
- (2020) Elena Crisà et al. LEUKEMIA
- In vitro functional characterization and in silico prediction of rare genetic variation in the bile acid and drug transporter, Na+-taurocholate co-transporting polypeptide (NTCP, SLC10A1)
- (2020) Laura E. Russell et al. MOLECULAR PHARMACEUTICS
- Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity
- (2020) Chase C. Suiter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic associations with clozapine-induced myocarditis in patients with schizophrenia
- (2020) Paul Lacaze et al. Translational Psychiatry
- Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation
- (2020) Volker M. Lauschke et al. npj Genomic Medicine
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
- (2020) Adarsh Bhimraj et al. CLINICAL INFECTIOUS DISEASES
- Ethnogeographic and inter-individual variability of human ABC transporters
- (2020) Qingyang Xiao et al. HUMAN GENETICS
- Variant discovery using next-generation sequencing and its future role in pharmacogenetics
- (2020) Laura E Russell et al. PHARMACOGENOMICS
- Towards harmonizing guidance for genome-informed drug treatment interventions: The show must go on
- (2020) Stefania Koutsilieri et al. PHARMACOLOGICAL RESEARCH
- 2020 American College of Rheumatology Guideline for the Management of Gout
- (2020) John D. FitzGerald et al. ARTHRITIS CARE & RESEARCH
- Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century
- (2020) Dianne Pulte et al. Blood Cancer Journal
- Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost‐Effectiveness of Preemptive Pharmacogenetic Testing
- (2020) Yitian Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population
- (2020) Koya Fukunaga et al. JOURNAL OF HUMAN GENETICS
- Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
- (2020) Mats Dehlin et al. Nature Reviews Rheumatology
- Genome-wide Study Identifies Association between HLA-B∗55:01 and Self-Reported Penicillin Allergy
- (2020) Kristi Krebs et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Population-scale predictions of DPD and TPMT phenotypes using a quantitative pharmacogene-specific ensemble classifier
- (2020) Yitian Zhou et al. BRITISH JOURNAL OF CANCER
- Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- (2020) Stephen R. D. Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Intestinal Efflux Transporters P-gp and BCRP Are Not Clinically Relevant in Apixaban Disposition
- (2020) Jasleen K. Sodhi et al. PHARMACEUTICAL RESEARCH
- Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity
- (2020) Roberto Viviani et al. Translational Psychiatry
- Pharmacogenomics of COVID-19 therapies
- (2020) Takuto Takahashi et al. npj Genomic Medicine
- Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters
- (2020) Brahim Achour et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity
- (2019) Volker M. Lauschke et al. PHARMACOLOGY & THERAPEUTICS
- A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver Cohort
- (2019) Kathrin Klein et al. Frontiers in Genetics
- CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions
- (2019) Laura M. Spring et al. Current Oncology Reports
- Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing
- (2019) Volker M. Lauschke et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Genome‐wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol
- (2019) Deanna J. Brackman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
- (2019) Rory M. Shallis et al. BLOOD REVIEWS
- Development of the PG x‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐emptive Pharmacogenetic Testing
- (2019) Cathelijne H. van der Wouden et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
- (2019) Rachel Huddart et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guideline for CYP 2B6 and Efavirenz‐containing Antiretroviral Therapy
- (2019) Zeruesenay Desta et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1
- (2019) Samantha Medwid et al. DRUG METABOLISM AND DISPOSITION
- Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
- (2019) John F. Greden et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Targeted next generation sequencing as a tool for precision medicine
- (2019) Markus Gulilat et al. BMC Medical Genomics
- Impact of ADCY9 Genotype on Response to Anacetrapib
- (2019) Jemma C. Hopewell et al. CIRCULATION
- Applying Multiplex Assays to Understand Variation in Pharmacogenes
- (2019) Melissa Chiasson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers
- (2019) Houda Hachad et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Finding a Place for Pharmacogenetics in the Electronic Health Record
- (2019) Terah Collins et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care
- (2019) Paul C. D. Bank et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Genomics education in nursing in Hong Kong, Taiwan and Mainland China
- (2019) Sek Ying Chair et al. INTERNATIONAL NURSING REVIEW
- Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey
- (2019) Nataša Karas Kuželički et al. PHARMACOGENOMICS
- Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network
- (2019) Hana Zouk et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics‐Based Patient Care Program in a Real‐World Setting
- (2019) Richard B. Kim CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Teaching of Personalized Dentistry in North American Dental Schools: Changes from 2014 to 2017
- (2019) Linda Zheng et al. JOURNAL OF DENTAL EDUCATION
- Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care
- (2019) Markus Gulilat et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications
- (2019) Yusmiati Liau et al. PHARMACOGENOMICS
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- The genetic landscape of the human solute carrier (SLC) transporter superfamily
- (2019) Lena Schaller et al. HUMAN GENETICS
- Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients
- (2019) Line S. Bråten et al. NEUROPSYCHOPHARMACOLOGY
- Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements
- (2019) Rawan Shekhani et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease
- (2019) Aleksejs Sazonovs et al. GASTROENTEROLOGY
- Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
- (2018) Marin M. Jukić et al. AMERICAN JOURNAL OF PSYCHIATRY
- Impacts of incorporating personal genome sequencing into graduate genomics education: a longitudinal study over three course years
- (2018) Michael D. Linderman et al. BMC Medical Genomics
- Pharmacogenomics of GPCR Drug Targets
- (2018) Alexander S. Hauser et al. CELL
- Adenylate Cyclase Type 9 (ADCY9) Inactivation Protects from Atherosclerosis Only in the Absence of Cholesteryl Ester Transfer Protein (CETP)
- (2018) Yohann Rautureau et al. CIRCULATION
- How to Consider Rare Genetic Variants in Personalized Drug Therapy
- (2018) Volker M. Lauschke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Interindividual Differences in the Expression of ATP-Binding Cassette and Solute Carrier Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human ABCC3 Gene
- (2018) Tomoki Takechi et al. DRUG METABOLISM AND DISPOSITION
- Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
- (2018) Katharina Schwarze et al. GENETICS IN MEDICINE
- Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics
- (2018) Jonathan B. Wagner et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
- (2018) Federico Rossari et al. Journal of Hematology & Oncology
- Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility
- (2018) Paul Bradley et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis
- (2018) Kaarina Kowalec et al. NATURE GENETICS
- Somatic mutations precede acute myeloid leukemia years before diagnosis
- (2018) Pinkal Desai et al. NATURE MEDICINE
- The Third Revolution in Sequencing Technology
- (2018) Erwin L. van Dijk et al. TRENDS IN GENETICS
- Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations
- (2018) Michael Buege et al. Cancers
- Ivosidenib: First Global Approval
- (2018) Sohita Dhillon DRUGS
- When will clinical trials finally reflect diversity?
- (2018) Todd C. Knepper et al. NATURE
- An optimized prediction framework to assess the functional impact of pharmacogenetic variants
- (2018) Yitian Zhou et al. PHARMACOGENOMICS JOURNAL
- Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
- (2018) Guoli Li et al. PLoS One
- Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis
- (2018) Haixia Chen et al. Frontiers in Pharmacology
- Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure
- (2018) Andrew Rowland et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- From Endogenous Compounds as Biomarkers to Plasma‐Derived Nanovesicles as Liquid Biopsy; Has the Golden Age of Translational PK ‐ ADME ‐ DDI Science Finally Arrived?
- (2018) David Rodrigues et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records
- (2018) Tõnis Tasa et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- A call for deep-learning healthcare
- (2018) Beau Norgeot et al. NATURE MEDICINE
- Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
- (2018) Ching-Hon Pui et al. Nature Reviews Clinical Oncology
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic variability and population diversity of the human SLCO (OATP) transporter family
- (2018) Boyao Zhang et al. PHARMACOLOGICAL RESEARCH
- Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data
- (2018) Yitian Zhou et al. Frontiers in Pharmacology
- Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?
- (2018) Emanuel Nicolas et al. Cancers
- Dabrafenib plus trametinib in patients with previously untreated BRAF V600E -mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
- (2017) David Planchard et al. LANCET ONCOLOGY
- Drug development in the era of precision medicine
- (2017) Sarah A. Dugger et al. NATURE REVIEWS DRUG DISCOVERY
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Strategies for integrating personalized medicine into healthcare practice
- (2017) Daryl E Pritchard et al. Personalized Medicine
- Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation
- (2017) Satoshi Ueshima et al. Pharmacogenetics and Genomics
- OCT1 pharmacogenetics in pain management: is a clinical application within reach?
- (2017) Mladen V Tzvetkov PHARMACOGENOMICS
- Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
- (2017) M Verbelen et al. PHARMACOGENOMICS JOURNAL
- Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials
- (2017) Zhi-qiao Xu et al. BMJ Open
- Genetic variation in human drug-related genes
- (2017) Charlotta Pauline Irmgard Schärfe et al. Genome Medicine
- Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice
- (2017) Ramiya Kumar et al. PLoS One
- Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial
- (2017) Lindsay S. Elliott et al. PLoS One
- Educational strategies to enable expansion of pharmacogenomics-based care
- (2016) K. W. Weitzel et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality
- (2016) Jennifer L. St. Sauver et al. AMERICAN JOURNAL OF MEDICINE
- Advancing Pharmacogenomics Education in the Core PharmD Curriculum through Student Personal Genomic Testing
- (2016) Solomon M. Adams et al. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
- IDH mutations in cancer and progress toward development of targeted therapeutics
- (2016) L. Dang et al. ANNALS OF ONCOLOGY
- Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes
- (2016) SM Han et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
- (2016) Kelly E. Caudle et al. GENETICS IN MEDICINE
- Rare genetic variants in cellular transporters, metabolic enzymes and nuclear receptors can be important determinants of interindividual differences in drug response
- (2016) Mikael Kozyra et al. GENETICS IN MEDICINE
- Prediction of CYP2D6 phenotype from genotype across world populations
- (2016) Andrea Gaedigk et al. GENETICS IN MEDICINE
- The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
- (2016) Volker Lauschke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records
- (2016) Sara L. Van Driest et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasmid-based one-pot saturation mutagenesis
- (2016) Emily E Wrenbeck et al. NATURE METHODS
- Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine
- (2016) Kathleen M. Giacomini et al. NATURE REVIEWS DRUG DISCOVERY
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PGRNseq
- (2016) Adam S. Gordon et al. Pharmacogenetics and Genomics
- Requirements for comprehensive pharmacogenetic genotyping platforms
- (2016) Volker M Lauschke et al. PHARMACOGENOMICS
- The global spectrum of protein-coding pharmacogenomic diversity
- (2016) G E B Wright et al. PHARMACOGENOMICS JOURNAL
- Impact of germline and somatic missense variations on drug binding sites
- (2016) C Yan et al. PHARMACOGENOMICS JOURNAL
- Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study
- (2016) Frederick E. Dewey et al. SCIENCE
- Precision Medicine and Rare Genetic Variants
- (2016) Volker M. Lauschke et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
- (2016) Thomas J. Hwang et al. JAMA Internal Medicine
- Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists
- (2016) Amber Frick et al. Frontiers in Pharmacology
- Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate
- (2015) Diluk R W Kannangara et al. ANNALS OF THE RHEUMATIC DISEASES
- How effective are common medications: a perspective based on meta-analyses of major drugs
- (2015) Stefan Leucht et al. BMC Medicine
- Adverse drug reactions in special populations - the elderly
- (2015) E. A. Davies et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCLINICAL PERSPECTIVE
- (2015) Jean-Claude Tardif et al. Circulation-Cardiovascular Genetics
- Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
- (2015) LV Kalman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response
- (2015) CC Wen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort
- (2015) Oliver Gautschi et al. Journal of Thoracic Oncology
- Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
- (2015) Didier Meulendijks et al. LANCET ONCOLOGY
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- Genetic variation in the human cytochrome P450 supergene family
- (2015) Kohei Fujikura et al. Pharmacogenetics and Genomics
- Somatic mutation in cancer and normal cells
- (2015) I. Martincorena et al. SCIENCE
- Pharmacogenomic Determinants of the Cardiovascular Effects of DalcetrapibCLINICAL PERSPECTIVE
- (2015) Jean-Claude Tardif et al. Circulation-Cardiovascular Genetics
- The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy
- (2015) D. Brixner et al. JOURNAL OF MEDICAL ECONOMICS
- Nanopore-based Fourth-generation DNA Sequencing Technology
- (2015) Yanxiao Feng et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon Cancer Treatment (NCCTG N0147)
- (2014) Adam M. Lee et al. JNCI-Journal of the National Cancer Institute
- Deep mutational scanning: a new style of protein science
- (2014) Douglas M Fowler et al. NATURE METHODS
- Towards Precision Medicine: Advances in Computational Approaches for the Analysis of Human Variants
- (2013) Thomas A. Peterson et al. JOURNAL OF MOLECULAR BIOLOGY
- Genetic alterations defining NSCLC subtypes and their therapeutic implications
- (2013) Larissa A. Pikor et al. LUNG CANCER
- A Randomized Trial of Genotype-Guided Dosing of Warfarin
- (2013) Munir Pirmohamed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomics in early-phase clinical development
- (2013) Tal Burt et al. PHARMACOGENOMICS
- HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
- (2013) E Genin et al. PHARMACOGENOMICS JOURNAL
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
- (2012) Patrick A. Flume et al. CHEST
- Compartment-Specific Gene Regulation of the CAR Inducer Efavirenz In Vivo
- (2012) H E Meyer zu Schwabedissen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions
- (2012) John D Clarke et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacogenetic tests: the need for a level playing field
- (2012) Munir Pirmohamed et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects
- (2012) S C Sim et al. PHARMACOGENOMICS JOURNAL
- An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People
- (2012) M. R. Nelson et al. SCIENCE
- EGFR Mutations and Lung Cancer
- (2011) Gilda da Cunha Santos et al. Annual Review of Pathology-Mechanisms of Disease
- Challenges in studying genomic structural variant formation mechanisms: The short-read dilemma and beyond
- (2011) Megumi Onishi-Seebacher et al. BIOESSAYS
- Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
- (2011) J. Hasford et al. BLOOD
- The Emerging Role of Electronic Medical Records in Pharmacogenomics
- (2011) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In Vitro Assessment of the Allelic Variants of Cytochrome P450
- (2011) Masahiro Hiratsuka Drug Metabolism and Pharmacokinetics
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity
- (2011) Ute I. Schwarz et al. Pharmacogenetics and Genomics
- The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients
- (2011) Kelly A. Birdwell et al. Pharmacogenetics and Genomics
- Pharmacogenetics in randomized controlled trials: considerations for trial design
- (2011) Frederieke H van der Baan et al. PHARMACOGENOMICS
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients
- (2010) E Ngaimisi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort
- (2010) D. F. Carr et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Organic anion transporting polypeptide 1a/1b–knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs
- (2010) Evita van de Steeg et al. JOURNAL OF CLINICAL INVESTIGATION
- CYP2D6 in the brain: genotype effects on resting brain perfusion
- (2010) J Kirchheiner et al. MOLECULAR PSYCHIATRY
- Genome-wide association studies in pharmacogenomics
- (2010) Ann K. Daly NATURE REVIEWS GENETICS
- Genome-wide association studies in pharmacogenomics
- (2010) Alison A. Motsinger-Reif et al. Pharmacogenetics and Genomics
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- (2010) Michael A Becker et al. ARTHRITIS RESEARCH & THERAPY
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Codeine, Ultrarapid-Metabolism Genotype, and Postoperative Death
- (2009) Catherine Ciszkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Next generation disparities in human genomics: concerns and remedies
- (2009) Anna C. Need et al. TRENDS IN GENETICS
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-Time DNA Sequencing from Single Polymerase Molecules
- (2008) J. Eid et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now